FOXO3 and precursor B-cell acute lymphoblastic leukemia: Immunoblots against FOXO3 and PRDM1 confirmed expression in 697 and other B-ALL cell lines (Fig. 2E), as well as markedly increased expression in 697 cells transduced with the expression constructs (Fig. 2F).